Antimicrobial peptides as model molecules for the development of novel antiviral agents in aquaculture.

IBMC, Miguel Hernández University, 03202, Elche, Spain.
Mini Reviews in Medicinal Chemistry (Impact Factor: 3.19). 09/2009; 9(10):1159-64. DOI: 10.2174/138955709789055171
Source: PubMed

ABSTRACT Antimicrobial peptides (AMPs) are one of the components of the non-specific immune system that operate first lines of protection in many animal species including fish. They exert broad-spectrum antimicrobial activity, apart from many other potential roles in innate immunity, and represent a promising class of antiviral agents. Recent advances in understanding the mechanisms of their antiviral action(s) indicate that they have a dual role in antiviral defence, acting not only directly on the virion but also on the host cell. Despite the acute problems of viral diseases and restrictions in using chemicals in aquaculture, few but successful attempts to assess the antiviral activities of fish AMPs have been reported. This review focuses on the antiviral activities and mechanisms of action of some AMPs, and their potential relevance in the aquaculture industry, one of the most important sources of fishery products in the near future. It is a matter of notable concern to understand whether the AMPs can be used as model molecules for designing antiviral drugs that might help to solve the problems with viruses in the fish farming industry worldwide. In addition, because fish rely more heavily on their innate immune defences than mammals, they might constitute a potential rich source of antiviral compounds for fighting against mammalian viral infections.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: It is well known that β-defensins are key components of the host innate immune response against pathogens and potentially provide a link between innate and adaptive immunity. In zebrafish (Danio rerio), a vertebrate model species in numerous biomedical fields, three β-defensin isoforms were recently identified. To our knowledge, however, studies describing antimicrobial or immunomodulatory properties of any of the zebrafish β-defensins isoforms are absent today. Since it is indubitable that deepening the study of zebrafish β-defensins would be of interest in this work we investigated whether or not the zebrafish β-defensin 2 (zfBD2) has the antiviral properties described for their vertebrate counterparts. Our in vitro and in vivo studies showed that zfBD2 has antiviral activity, immunomodulatory properties and, most importantly, is a potent viral DNA vaccine molecular adjuvant. In addition, a potential relationship between zfBD2 activity and the NF-kB signaling pathway is suggested. Altogether these results show that the zebrafish could be a suitable in vivo animal model to study the roles played by β-defensin 2 in viral diseases, vaccinology and even in clinical dermatology. To note that psoriasis can be induced in zebrafish and the over-expression of β-defensin 2 is implicated in the inflammatory response associated with this human skin disorder.
    Antiviral research 11/2013; DOI:10.1016/j.antiviral.2013.11.009 · 3.43 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Hepcidins are small cysteine-rich cationic antimicrobial peptides. The channel catfish (Ictalurus punctatus) hepcidin cDNA has been characterized, but recombinant protein expression and purification was not reported. I. punctatus hepcidin is comprised of 96 residues, with eight functionally important conserved cysteine residues located in the C-terminal region of the mature peptide, suggesting that this region is responsible for the antibacterial activity. In this study, a cDNA fragment (mCH) encoding the 25 amino acid mature peptide was cloned from channel catfish liver, and inserted into vector pET-32a(+) to produce a construct that expressed a hexahistidine-tagged thioredoxin (trxA) fusion protein that was cleavable using enterokinase. The trxA–mCH fusion protein was expressed in Escherichia coli BL21 (DE3) at 25 °C, using 1 mM IPTG for induction. Greater than 80% of the fusion protein was expressed solubly, but was not biologically active. Removal of the trxA fusion partner by enterokinase resulted in mCH that exhibited antibacterial activity against two Gram-positive (Listeria monocytogenes and Staphylococcus aureus), and two Gram-negative (E. coli and Pseudomonas aeruginosa) bacteria.
    Protein Expression and Purification 01/2013; DOI:10.1016/j.pep.2013.11.001 · 1.51 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Human cathelicidin LL-37 protects against infections and endotoxin-induced inflammation. In a recent study we have shown that IG-19, a LL-37-derived peptide, protects in a murine model of arthritis. Cytokine IL-32 is elevated and directly associated with the disease severity of inflammatory arthritis. Therefore, in this study we examined the effects of LL-37 and IG-19 on IL-32-induced responses in human peripheral blood-derived mononuclear cells (PBMC) and macrophages. We showed that CD14+ monocytes are the primary cells that produce pro-inflammatory TNF-α following stimulation of PBMC with IL-32. We demonstrated that LL-37 and IG-19 significantly suppress IL-32-induced production of pro-inflammatory cytokines e.g. TNF-α and IL-1β, without altering chemokine production. In contrast, LL-37 and IG-19 enhance the production of the anti-inflammatory cytokine IL-1RA. Further mechanistic studies revealed that LL-37 and IG-19 suppress IL-32-mediated phosphorylation of Fyn (Y420) Src kinase. In contrast, IL-32-mediated phosphorylation of AKT-1 (T308) and MKP-1 (S359) is not suppressed by the peptides. LL-37 and IG-19 alone induce the phosphorylation of MKP-1 (S359), which is a known negative regulator of inflammation. Furthermore, the peptides induce the activity of p44/42 MAPK, which is known to phosphorylate MKP-1 (S359). This is the first study to demonstrate the regulation of IL-32-induced inflammation by LL-37 and its derivative peptide IG-19. The mechanistic results from this study suggest that regulation of immune-mediated inflammation by these peptides may be controlled by the dual phosphatase MKP-1. We speculate that LL-37 and its derivatives may contribute to the control of immune-mediated inflammatory diseases. This article is protected by copyright. All rights reserved.
    Immunology 03/2014; DOI:10.1111/imm.12291 · 3.74 Impact Factor


Available from
Jun 5, 2014